Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia (2023)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FM ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; LIMA, KELI CRISTINA DE - FM ; CARVALHO, MARIA FERNANDA LOPES - ICB ; MARTINS, DIEGO ANTONIO PEREIRA - FMRP ; NOGUEIRA, FREDERICO LISBOA - FM ; MIRANDA, LÍVIA BASSANI LINS DE - ICB ; NASCIMENTO, MARIANE CRISTINA DO - FM ; Rego, Eduardo Magalhães - FM
- Unidades: FM; ICB; FMRP
- DOI: https://doi.org/10.3390/ijms242316899
- Subjects: FARMACOLOGIA; LEUCEMIA MIELOIDE AGUDA; NEOPLASIAS POR TIPO HISTOLÓGICO; ANTINEOPLÁSICOS; APOPTOSE; PROTEÍNAS PROTO-ONCOGÊNICAS; COMPOSTOS HETEROCÍCLICOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: International Journal of Molecular Sciences
- ISSN: 1422-0067
- Volume/Número/Paginação/Ano: v. 24, n. 23, art. 16899, 12 p., 2023
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
LIMA, Keli Cristina de et al. Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia. International Journal of Molecular Sciences, v. 24, n. 23, p. 12 , 2023Tradução . . Disponível em: https://doi.org/10.3390/ijms242316899. Acesso em: 29 maio 2024. -
APA
Lima, K. C. de, Carvalho, M. F. L., Pereira-Martins, D. A., Nogueira, F. L., Miranda, L. B. L. de, Mariane Cristina do Nascimento,, et al. (2023). Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia. International Journal of Molecular Sciences, 24( 23), 12 . doi:https://doi.org/10.3390/ijms242316899 -
NLM
Lima KC de, Carvalho MFL, Pereira-Martins DA, Nogueira FL, Miranda LBL de, Mariane Cristina do Nascimento, Cavaglieri R de C, Schuringa JJ, Rego EM, Machado Neto JA. Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia [Internet]. International Journal of Molecular Sciences. 2023 ; 24( 23): 12 .[citado 2024 maio 29 ] Available from: https://doi.org/10.3390/ijms242316899 -
Vancouver
Lima KC de, Carvalho MFL, Pereira-Martins DA, Nogueira FL, Miranda LBL de, Mariane Cristina do Nascimento, Cavaglieri R de C, Schuringa JJ, Rego EM, Machado Neto JA. Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia [Internet]. International Journal of Molecular Sciences. 2023 ; 24( 23): 12 .[citado 2024 maio 29 ] Available from: https://doi.org/10.3390/ijms242316899 - Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia
- Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia
- Estudo de células mesenquimais da medula óssea de pacientes com leucemia mielóide aguda e de indivíduos saudáveis em um ensaio de cocultivo com blastos leucêmicos
- Data mining in acute myeloid leukemia: identification of disease biomarkers, prognostic factors, novel targets, and potential drugs
- Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models
- The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells
- NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells
- NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells
- The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
- Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia
Informações sobre o DOI: https://doi.org/10.3390/ijms242316899 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | Pharmacological Inhibitio... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
